Medtech developing the Lenire neuromodulation tinnitus treatment
| Date | Round | Amount |
|---|---|---|
| Apr 2023 | Series B Neuromod Devices raised a EUR30M Series B (EUR15M equity led by Panakes Partners plus EUR15M EIB venture debt) to launch its Lenire tinnitus device in the US. | $30M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.